Oral Sildenafil in the Treatment of Erectile Dysfunction

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

1997 • 5,464 citations

Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study

1994 • 4,980 citations

Physiology of penile erection

1995 • 1,113 citations

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

1996 • 1,070 citations

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

1992 • 1,028 citations

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1993 • 825 citations

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil

1997 • 566 citations

Sildenafil, a novel effective oral therapy for male erectile dysfunction

1996 • 566 citations

Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction

1996 • 484 citations

Role of Nitric Oxide in the Physiology of Erection1

1995 • 259 citations

Clinical Guidelines Panel on Erectile Dysfunction: Summary Report on the Treatment of Organic Erectile Dysfunction

1996 • 215 citations

Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells

1998 • 198 citations

IMPOTENCE AND ITS NON‐SURGICAL MANAGEMENT

1997 • 18 citations